SUN2_HUMAN - dbPTM
SUN2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SUN2_HUMAN
UniProt AC Q9UH99
Protein Name SUN domain-containing protein 2
Gene Name SUN2
Organism Homo sapiens (Human).
Sequence Length 717
Subcellular Localization Nucleus inner membrane
Single-pass type II membrane protein . Nucleus envelope . Endosome membrane
Single-pass type II membrane protein .
Protein Description As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex, involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning. Specifically, SYNE2 and SUN2 assemble in arrays of transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow during actin-dependent nuclear movement. Required for interkinetic nuclear migration (INM) and essential for nucleokinesis and centrosome-nucleus coupling during radial neuronal migration in the cerebral cortex and during glial migration. Required for nuclear migration in retinal photoreceptor progenitors implicating association with cytoplasmic dynein-dynactin and kinesin motor complexes, and probably B-type lamins; SUN1 and SUN2 seem to act redundantly. The SUN1/2:KASH5 LINC complex couples telomeres to microtubules during meiosis; SUN1 and SUN2 seem to act at least partial redundantly. Anchors chromosome movement in the prophase of meiosis and is involved in selective gene expression of coding and non-coding RNAs needed for gametogenesis. Required for telomere attachment to nuclear envelope and gametogenesis. May also function on endocytic vesicles as a receptor for RAB5-GDP and participate in the activation of RAB5..
Protein Sequence MSRRSQRLTRYSQGDDDGSSSSGGSSVAGSQSTLFKDSPLRTLKRKSSNMKRLSPAPQLGPSSDAHTSYYSESLVHESWFPPRSSLEELHGDANWGEDLRVRRRRGTGGSESSRASGLVGRKATEDFLGSSSGYSSEDDYVGYSDVDQQSSSSRLRSAVSRAGSLLWMVATSPGRLFRLLYWWAGTTWYRLTTAASLLDVFVLTRRFSSLKTFLWFLLPLLLLTCLTYGAWYFYPYGLQTFHPALVSWWAAKDSRRPDEGWEARDSSPHFQAEQRVMSRVHSLERRLEALAAEFSSNWQKEAMRLERLELRQGAPGQGGGGGLSHEDTLALLEGLVSRREAALKEDFRRETAARIQEELSALRAEHQQDSEDLFKKIVRASQESEARIQQLKSEWQSMTQESFQESSVKELRRLEDQLAGLQQELAALALKQSSVAEEVGLLPQQIQAVRDDVESQFPAWISQFLARGGGGRVGLLQREEMQAQLRELESKILTHVAEMQGKSAREAAASLSLTLQKEGVIGVTEEQVHHIVKQALQRYSEDRIGLADYALESGGASVISTRCSETYETKTALLSLFGIPLWYHSQSPRVILQPDVHPGNCWAFQGPQGFAVVRLSARIRPTAVTLEHVPKALSPNSTISSAPKDFAIFGFDEDLQQEGTLLGKFTYDQDGEPIQTFHFQAPTMATYQVVELRILTNWGHPEYTCIYRFRVHGEPAH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Phosphorylation---MSRRSQRLTRYS
---CCHHHHHCHHCC
20.6727282143
9PhosphorylationSRRSQRLTRYSQGDD
CHHHHHCHHCCCCCC
29.7423401153
9 (in isoform 2)Phosphorylation-29.7427251275
11PhosphorylationRSQRLTRYSQGDDDG
HHHHCHHCCCCCCCC
10.5023927012
12 (in isoform 2)Phosphorylation-25.1327251275
12PhosphorylationSQRLTRYSQGDDDGS
HHHCHHCCCCCCCCC
25.1323927012
19PhosphorylationSQGDDDGSSSSGGSS
CCCCCCCCCCCCCCC
33.7623927012
20PhosphorylationQGDDDGSSSSGGSSV
CCCCCCCCCCCCCCC
33.7723401153
21PhosphorylationGDDDGSSSSGGSSVA
CCCCCCCCCCCCCCC
34.4023927012
22PhosphorylationDDDGSSSSGGSSVAG
CCCCCCCCCCCCCCC
49.4723927012
22 (in isoform 2)Phosphorylation-49.4727251275
25PhosphorylationGSSSSGGSSVAGSQS
CCCCCCCCCCCCCCC
25.7623927012
26PhosphorylationSSSSGGSSVAGSQST
CCCCCCCCCCCCCCC
21.1822167270
30PhosphorylationGGSSVAGSQSTLFKD
CCCCCCCCCCCCCCC
15.9523401153
30 (in isoform 2)Phosphorylation-15.9527251275
32PhosphorylationSSVAGSQSTLFKDSP
CCCCCCCCCCCCCCC
28.8622167270
33PhosphorylationSVAGSQSTLFKDSPL
CCCCCCCCCCCCCCC
28.6922167270
38 (in isoform 2)Phosphorylation-26.8227251275
38PhosphorylationQSTLFKDSPLRTLKR
CCCCCCCCCCHHHHH
26.8222167270
42PhosphorylationFKDSPLRTLKRKSSN
CCCCCCHHHHHHCCC
44.2923401153
54PhosphorylationSSNMKRLSPAPQLGP
CCCCCCCCCCCCCCC
24.0523927012
62PhosphorylationPAPQLGPSSDAHTSY
CCCCCCCCCCCCCHH
38.7729978859
63PhosphorylationAPQLGPSSDAHTSYY
CCCCCCCCCCCCHHC
41.7828464451
67PhosphorylationGPSSDAHTSYYSESL
CCCCCCCCHHCCCCC
21.8323927012
68PhosphorylationPSSDAHTSYYSESLV
CCCCCCCHHCCCCCC
16.5327080861
69PhosphorylationSSDAHTSYYSESLVH
CCCCCCHHCCCCCCC
16.5027080861
71PhosphorylationDAHTSYYSESLVHES
CCCCHHCCCCCCCCC
16.6926657352
73PhosphorylationHTSYYSESLVHESWF
CCHHCCCCCCCCCCC
29.74-
84PhosphorylationESWFPPRSSLEELHG
CCCCCCCHHHHHHHC
45.0823663014
85 (in isoform 2)Phosphorylation-40.8727251275
85PhosphorylationSWFPPRSSLEELHGD
CCCCCCHHHHHHHCC
40.8723663014
107PhosphorylationRVRRRRGTGGSESSR
CHHHHCCCCCCHHHH
36.2427273156
110PhosphorylationRRRGTGGSESSRASG
HHCCCCCCHHHHHCC
35.3323401153
112PhosphorylationRGTGGSESSRASGLV
CCCCCCHHHHHCCCC
27.1627273156
113PhosphorylationGTGGSESSRASGLVG
CCCCCHHHHHCCCCC
28.0223401153
116 (in isoform 2)Phosphorylation-31.3927251275
116PhosphorylationGSESSRASGLVGRKA
CCHHHHHCCCCCCCC
31.3923401153
124 (in isoform 2)Phosphorylation-38.84-
124PhosphorylationGLVGRKATEDFLGSS
CCCCCCCCHHHCCCC
38.8428450419
130 (in isoform 2)Phosphorylation-24.3922210691
130PhosphorylationATEDFLGSSSGYSSE
CCHHHCCCCCCCCCC
24.3928796482
131PhosphorylationTEDFLGSSSGYSSED
CHHHCCCCCCCCCCC
26.4523401153
132PhosphorylationEDFLGSSSGYSSEDD
HHHCCCCCCCCCCCC
43.3728796482
134PhosphorylationFLGSSSGYSSEDDYV
HCCCCCCCCCCCCCC
15.8028796482
135PhosphorylationLGSSSGYSSEDDYVG
CCCCCCCCCCCCCCC
30.6728796482
136 (in isoform 2)Phosphorylation-36.2422210691
136PhosphorylationGSSSGYSSEDDYVGY
CCCCCCCCCCCCCCC
36.2428796482
140PhosphorylationGYSSEDDYVGYSDVD
CCCCCCCCCCCCCCC
14.2226657352
143PhosphorylationSEDDYVGYSDVDQQS
CCCCCCCCCCCCCCC
7.5228796482
144PhosphorylationEDDYVGYSDVDQQSS
CCCCCCCCCCCCCCC
25.8128796482
150PhosphorylationYSDVDQQSSSSRLRS
CCCCCCCCCHHHHHH
26.9328450419
151PhosphorylationSDVDQQSSSSRLRSA
CCCCCCCCHHHHHHH
28.1728450419
152 (in isoform 2)Phosphorylation-25.40-
152PhosphorylationDVDQQSSSSRLRSAV
CCCCCCCHHHHHHHH
25.4028450419
153PhosphorylationVDQQSSSSRLRSAVS
CCCCCCHHHHHHHHH
36.9628450419
154 (in isoform 2)Phosphorylation-35.75-
157PhosphorylationSSSSRLRSAVSRAGS
CCHHHHHHHHHHHHH
37.3022210691
160PhosphorylationSRLRSAVSRAGSLLW
HHHHHHHHHHHHHHH
19.0122210691
266PhosphorylationEGWEARDSSPHFQAE
CCCCCCCCCCCHHHH
39.9723401153
267PhosphorylationGWEARDSSPHFQAEQ
CCCCCCCCCCHHHHH
27.0421712546
282PhosphorylationRVMSRVHSLERRLEA
HHHHHHHHHHHHHHH
29.1224719451
300UbiquitinationEFSSNWQKEAMRLER
HHCHHHHHHHHHHHH
38.7721906983
324PhosphorylationQGGGGGLSHEDTLAL
CCCCCCCCHHHHHHH
28.2722210691
328PhosphorylationGGLSHEDTLALLEGL
CCCCHHHHHHHHHHH
15.7922210691
335UbiquitinationTLALLEGLVSRREAA
HHHHHHHHHHHHHHH
2.0021906983
344UbiquitinationSRREAALKEDFRRET
HHHHHHHHHHHHHHH
50.97-
375UbiquitinationQDSEDLFKKIVRASQ
HCCHHHHHHHHHHHH
49.22-
381PhosphorylationFKKIVRASQESEARI
HHHHHHHHHHHHHHH
24.74-
392UbiquitinationEARIQQLKSEWQSMT
HHHHHHHHHHHHHCC
41.8321906983
399O-linked_GlycosylationKSEWQSMTQESFQES
HHHHHHCCHHHHHHH
34.14OGP
409UbiquitinationSFQESSVKELRRLED
HHHHHHHHHHHHHHH
53.6421906983
427UbiquitinationGLQQELAALALKQSS
HHHHHHHHHHHHCCH
13.1421906983
444UbiquitinationEEVGLLPQQIQAVRD
HHHCCCHHHHHHHHH
53.6421906983
491UbiquitinationQLRELESKILTHVAE
HHHHHHHHHHHHHHH
32.15-
502UbiquitinationHVAEMQGKSAREAAA
HHHHHCCCCHHHHHH
24.852190698
510PhosphorylationSAREAAASLSLTLQK
CHHHHHHHHHHEEEE
17.4822985185
514PhosphorylationAAASLSLTLQKEGVI
HHHHHHHEEEECCCC
24.6219413330
533UbiquitinationEQVHHIVKQALQRYS
HHHHHHHHHHHHHHC
29.29-
537UbiquitinationHIVKQALQRYSEDRI
HHHHHHHHHHCCCCC
45.3321906983
549PhosphorylationDRIGLADYALESGGA
CCCCHHHHHHHCCCC
13.89-
553PhosphorylationLADYALESGGASVIS
HHHHHHHCCCCEEEE
43.2927251275
557PhosphorylationALESGGASVISTRCS
HHHCCCCEEEECCCC
24.2127251275
560PhosphorylationSGGASVISTRCSETY
CCCCEEEECCCCCCC
13.9827251275
561PhosphorylationGGASVISTRCSETYE
CCCEEEECCCCCCCC
25.2727251275
564PhosphorylationSVISTRCSETYETKT
EEEECCCCCCCCHHH
29.6827251275
566PhosphorylationISTRCSETYETKTAL
EECCCCCCCCHHHHH
15.4627251275
567PhosphorylationSTRCSETYETKTALL
ECCCCCCCCHHHHHH
19.9727251275
569PhosphorylationRCSETYETKTALLSL
CCCCCCCHHHHHHHH
24.2327251275
574 (in isoform 2)Phosphorylation-3.7627251275
581 (in isoform 2)Phosphorylation-7.1927251275
622O-linked_GlycosylationLSARIRPTAVTLEHV
EEEEECCCEEEHHCC
24.74OGP
634O-linked_GlycosylationEHVPKALSPNSTISS
HCCCCCCCCCCCCCC
27.2230379171
636N-linked_GlycosylationVPKALSPNSTISSAP
CCCCCCCCCCCCCCC
48.7019159218
637PhosphorylationPKALSPNSTISSAPK
CCCCCCCCCCCCCCC
30.4223312004
638PhosphorylationKALSPNSTISSAPKD
CCCCCCCCCCCCCCC
31.3623312004
640PhosphorylationLSPNSTISSAPKDFA
CCCCCCCCCCCCCEE
22.1223312004
641O-linked_GlycosylationSPNSTISSAPKDFAI
CCCCCCCCCCCCEEE
44.7530379171
641PhosphorylationSPNSTISSAPKDFAI
CCCCCCCCCCCCEEE
44.7523312004
683O-linked_GlycosylationTFHFQAPTMATYQVV
EEEEECCCCCEEEEE
23.58OGP

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
12SPhosphorylationKinaseATRQ13535
PSP
12SPhosphorylationKinasePRKACAP17612
GPS
12SPhosphorylationKinasePKA-FAMILY-GPS
12SPhosphorylationKinasePKA_GROUP-PhosphoELM
54SPhosphorylationKinasePRKACAP17612
GPS
54SPhosphorylationKinasePKA-FAMILY-GPS
54SPhosphorylationKinasePKA_GROUP-PhosphoELM
116SPhosphorylationKinasePRKACAP17612
GPS
116SPhosphorylationKinasePKA-FAMILY-GPS
116SPhosphorylationKinasePKA_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SUN2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SUN2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SYNE1_HUMANSYNE1physical
22632968
SYNE2_HUMANSYNE2physical
22632968
FBW1B_HUMANFBXW11physical
28514442
FKB14_HUMANFKBP14physical
28514442
DHRS4_HUMANDHRS4physical
28514442
RAB5A_HUMANRAB5Aphysical
28514442
RAB5C_HUMANRAB5Cphysical
28514442
PK3CA_HUMANPIK3CAphysical
28514442
UGPA_HUMANUGP2physical
28514442
PI42C_HUMANPIP4K2Cphysical
28514442
PI42B_HUMANPIP4K2Bphysical
28514442
MAP2_HUMANMETAP2physical
28514442
POTEF_HUMANPOTEFphysical
28514442
PI42A_HUMANPIP4K2Aphysical
28514442
ZO1_HUMANTJP1physical
28514442
CHMP6_HUMANCHMP6physical
28514442
ACADS_HUMANACADSphysical
28514442
LMNA_HUMANLMNAphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SUN2_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-636, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54, AND MASSSPECTROMETRY.
"A mass spectrometry-based proteomic approach for identification ofserine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as aprotein kinase A substrate.";
Gronborg M., Kristiansen T.Z., Stensballe A., Andersen J.S., Ohara O.,Mann M., Jensen O.N., Pandey A.;
Mol. Cell. Proteomics 1:517-527(2002).
Cited for: PHOSPHORYLATION AT SER-12; SER-54 AND SER-116.

TOP